<?xml version="1.0" encoding="UTF-8"?>
<ref id="feb213806-bib-0049">
 <label>49</label>
 <mixed-citation publication-type="journal" id="feb213806-cit-0049">
  <string-name>
   <surname>Kuhn</surname>
   <given-names>DJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Chen</surname>
   <given-names>Q</given-names>
  </string-name>, 
  <string-name>
   <surname>Voorhees</surname>
   <given-names>PM</given-names>
  </string-name>, 
  <string-name>
   <surname>Strader</surname>
   <given-names>JS</given-names>
  </string-name>, 
  <string-name>
   <surname>Shenk</surname>
   <given-names>KD</given-names>
  </string-name>, 
  <string-name>
   <surname>Sun</surname>
   <given-names>CM</given-names>
  </string-name>, 
  <string-name>
   <surname>Demo</surname>
   <given-names>SD</given-names>
  </string-name>, 
  <string-name>
   <surname>Bennett</surname>
   <given-names>MK</given-names>
  </string-name>, 
  <string-name>
   <surname>van Leeuwen</surname>
   <given-names>FW</given-names>
  </string-name>, 
  <string-name>
   <surname>Chanan‐Khan</surname>
   <given-names>AA</given-names>
  </string-name> and 
  <italic>et al</italic> (
  <year>2007</year>) 
  <article-title>Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin‐proteasome pathway, against preclinical models of multiple myeloma</article-title>. 
  <source xml:lang="en">Blood</source>
  <volume>110</volume>, 
  <fpage>3281</fpage>–
  <lpage>3290</lpage>.
  <pub-id pub-id-type="pmid">17591945</pub-id>
 </mixed-citation>
</ref>
